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Abdominal pain is a frequent symptom of peritoneal cavity irritation, but little is known about the role of
the receptors for irritant substances, transient receptor potential vanilloid 1 (TRPV1) and ankyrin 1
(TRPA1), in this painful condition. Thus, we investigated the abdominal nociception caused by peritoneal
stimulation with TRPV1 (capsaicin) and TRPA1 (allyl isothiocyanate, AITC) agonists and their mechanisms
in rats. The intraperitoneal (i.p.) injection of either capsaicin or AITC (0.03–10 mg/kg) induced short-term
(up to 20 min) and dose-dependent abdominal nociception, and also produced c-fos expression in spinal
afferents of the dorsal horn. TRPV1 antagonism prevented (9474% inhibition) nociception induced by
capsaicin but not by AITC. In contrast, the TRPA1 antagonism almost abolished AITC-induced nociception
(9572% inhibition) without altering the capsaicin response. Moreover, nociception induced by either
capsaicin or AITC was reduced by the desensitisation of TRPV1-positive sensory ﬁbres with resinifer-
atoxin (73718 and 76715% inhibitions, respectively) and by the NK1 receptor antagonist aprepitant
(5675 and 5378% inhibitions, respectively). Likewise, the i.p. injections of capsaicin or AITC increased
the content of substance P in the peritoneal ﬂuid. Nevertheless, neither the mast cell membrane
stabiliser cromoglycate, nor the H1 antagonist promethazine, nor depletion of peritoneal macrophages
affected abdominal nociception induced either by capsaicin or AITC. Accordingly, neither capsaicin nor
AITC increased the histamine content in the peritoneal ﬂuid or provoked peritoneal mast cell
degranulation in vitro. Collectively, our ﬁndings suggest that TRPV1 and TRPA1 stimulation in the
peritoneum produces abdominal nociception that is mediated by sensory ﬁbres activation.
& 2013 Elsevier B.V. All rights reserved.1. Introduction
Transient receptor potential vanilloid 1 (TRPV1) and ankyrin 1
(TRPA1) are non-selective cation channels involved in the periph-
eral detection of several painful stimuli (Andrade et al., 2012; Jara-
Oseguera et al., 2008; Moran et al., 2011). An important feature of
both channels is that they are activated by irritant substances,
such as capsaicin (the “hot” component of chilli peppers), which
activates TRPV1, and allyl isothiocyanate (AITC, the major compo-
nent of mustard oil), which stimulates TRPA1 (Moran et al., 2011).ll rights reserved.
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).TRPV1 and TRPA1 are usually co-expressed in a subset of small
diameter sensory ﬁbres together with the neuropeptide substance
P (Bautista et al., 2005; Story et al., 2003). It has been well
described that activation of TRPV1 and TRPA1 in the sensory
neurons releases neuropeptides and transmits painful stimuli to
the central nervous system, which causes pain (Cortright and
Szallasi, 2009; Geppetti et al., 2008). In fact, the receptors TRPV1
and TRPA1 have been implicated in painful processes observed in
somatic (such as skin and joints) and visceral (such as intestine,
pancreas and urinary bladder) organs (Akbar et al., 2008; Andrade
et al., 2012; Lapointe and Altier, 2011; Moran et al., 2011; Schwartz
et al., 2011). In addition to sensory neuron activation and neuro-
peptide release, mast cell stimulation and histamine secretion
have been implicated in nociception caused by triggering TRPA1
and TRPV1 in the skin and viscera (Andrade et al., 2008; Futamura
et al., 2009; Inoue et al., 1993; Massaad et al., 2004).
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brane of the body and consists of two layers: the parietal peritoneum
lines the abdomino-pelvic cavity and the visceral peritoneum reﬂects
over the external surface of the viscera (Tanaka et al., 2002). Diseases
involving the peritoneum are frequently encountered in medical
practices (Elsayes et al., 2006). The irritation or inﬂammation of the
peritoneum by chemical substances or microorganisms usually
induces abdominal pain, which is a common complaint in all settings
of medical practice (Flasar and Goldberg, 2006; Mactier et al., 1998).
The peritoneal cavity contains both visceral and somatic sensory
innervations and has a large number of resident cells, such as mast
cells (Anaf et al., 2006; Flasar and Goldberg, 2006; Lantéri-Minet
et al., 1993).
In addition, both TRPV1 and TRPA1 are expressed in somatic
and visceral sensory neurons, as well as in mast cells (Biro et al.,
1998; Malin et al., 2011; Prasad et al., 2008; Stander et al., 2004;
Weller et al., 2011), and are important receptors for chemical
irritants (Moran et al., 2011). However, the ability of such receptors
to induce abdominal pain after peritoneum stimulation and the
mechanisms involved are poorly understood. The goal of this
study was to investigate whether abdominal nociception is
induced by the activation of either TRPV1 or TRPA1 and some of
the mechanisms involved in this response.2. Material and methods
2.1. Animals
Adult male Wistar rats (200–250 g) bred in our animal house
were used in all of the experiments. The animals were housed in
groups of 5 to a cage in a controlled temperature environment
maintained at 2271 1C with a 12-h light/dark cycle (lights on from
6:00 a.m. to 6 p.m.) and fed standard lab chow and tap water ad
libitum. The animals were acclimated to the experimental room for at
least 2 h before the experiments. Each animal was used only once.
All of the experiments were carried out according to the current
guidelines for the care of laboratory animals and the ethical guide-
lines for the investigation of experimental pain in conscious animals
(Zimmermann, 1983). The number of animals and intensity of noxi-
ous stimuli used were the minimum necessary to demonstrate
consistent effects of the drug treatments. All of the protocols were
approved by the Ethics Committee of the Federal University of Santa
Maria (CIETEA, protocol number: 029/2012).
2.2. Drugs
Capsaicin, allyl isothiocyanate (AITC), 4′-chloro-3-methoxycin-
namanilide (SB-366791), sodium cromoglycate, compound 48/80,
o-phthaldialdehyde, resiniferatoxin (RTX), metronidazole, HC-
030031, and histamine dihydrochloride were purchased from
Sigma (Sigma, St Louis, MO, USA). Camphor was purchased from
VETEC (Rio de Janeiro, Brazil). Promethazine was obtained from
Cristália (São Paulo, Brazil). Aprepitant (MK-869) was extracted
from commercially available capsules (Emends, Merck, USA), and
its identity and purity (greater than 98%) were conﬁrmed by
nuclear resonance methods. The stock solutions of capsaicin and
AITC were prepared in 90% ethanol and 10% Tween 80. Resinifer-
atoxin was diluted in 10% ethanol and 10% Tween 80 in phosphate-
buffered saline (PBS). Camphor and SB-366791 were suspended in
1% Tween 80 and 1% DMSO in PBS. Sodium cromoglycate,
compound 48/80, promethazine and aprepitant were diluted in
PBS for injection. The PBS had the following composition: 137 mM
NaCl and 10 mM sodium phosphate buffer (pH 7.4). The ﬁnal
concentrations of ethanol and Tween 80 did not exceed 1% and
also did not produce any effect on their own.2.3. Evaluation of capsaicin- and AITC-induced abdominal
nociception in rats
Animals were placed individually in chambers (transparent
glass boxes) and were allowed to adapt for 20 min before the
algogen injection. Abdominal nociception was elicited by the
intraperitoneal (i.p.) administration of either capsaicin or AITC.
The control animals received the same volume of the vehicle
(10 mL/kg, 0.95% ethanol and 0.05% Tween 80 in PBS). Abdominal
nociception was qualitatively evaluated using a scale from 0 to
3 points for each 10-min interval, as previously described with
some modiﬁcations (Schmauss and Yaksh, 1984). The abdominal
nociceptive score was assigned as follows: 0¼normal body posi-
tion of the rat and normal exploratory behaviour, 1¼ leaning
posture favouring the left or right body side, 2¼stretching of the
hindlimbs, dorsoﬂexion of the hind paws, and body stretched and
ﬂat on the bottom, frequently with the pelvis rotated sideward,
3¼contraction of the abdominal muscles followed by a stretching
of the body and extension of the hind limbs (writhing response).
Abdominal nociception was also quantitatively measured by the
amount of time an animal presented a nociceptive score ≥1 timed
in 10-min blocks (Schmauss and Yaksh, 1984).
Initially, we observed the abdominal nociception elicited by the
i.p. administration of capsaicin (0.1 mg/kg) or AITC (3 mg/kg) at
10-min intervals over a total time of 30 min. Afterwards, a dose–
response curve for the abdominal nociception induced by the i.p.
administration of capsaicin (0.03–0.3 mg/kg) or AITC (1–10 mg/kg)
was carried out. For this experiment, the abdominal nociception time
and score were observed for 10 min after the algogen injection.
To observe a possible co-participation of the TRPV1 and TRPA1
receptors in the abdominal nociception induced by capsaicin or AITC,
we have co-injected these substances. Then, we have co-administered
the capsaicin (0.01 mg/kg, i.p.) and AITC (1 mg/kg, i.p.) in doses that
did not induce nociception previously. In addition, we have also co-
injected the TRPV1 (SB-366791, 0.25 mg/kg, i.p.) and TRPA1 (camphor,
0.25 mg/kg, s.c.) antagonists 30 min before the administration of
capsaicin (0.01 mg/kg, i.p.) plus AITC (3 mg/kg, i.p.) or its vehicles.2.4. Fos immunohistochemistry and quantiﬁcation
Fos immunohistochemistry was performed as previously described
(Bonaz et al., 1994, 2000). Rats were sacriﬁced 10 min after i.p.
injection of vehicle, capsaicin (0.1 mg/kg, i.p.) or AITC (3 mg/kg,
i.p.). Animals were transcardially perfused with 0.1 M phosphate
buffer (PBS; pH 7.4) followed by 4% paraformaldehyde in 0.1 M
PBS. Spinal cords segments were rapidly removed, postﬁxed for
24 h at the same ﬁxative, and subsequently cryoprotected over-
night in 30% sucrose in 0.1 M PBS. Frozen coronal sections (40 mm)
of the spinal cord (segments thoracic or cervical) were cut on a
cryostat (Leica 1850, Germany) and processed for Fos-IR. Free-
ﬂoating sections were incubated for 16–18 h at 4 1C with the
primary antibody (Fos AB-5 rabbit polyclonal antibody, Santa Cruz
Biotechnology, Santa Cruz, CA, USA; dilution 1:1000 in PBS 0.02 M,
containing 0.5% Triton X-100 and 10% normal goat serum) and
then with a biotinylated secondary antibody (goat anti-rabbit,
Dako, USA; dilution 1: 250) for 2 h at room temperature. Sections
were ﬁnally processed for avidin-biotin-peroxidase using diami-
nobenzidine as a chromogen (Sigma, St Louis, MO, USA), then
mounted on gelatin-coated slides, dehydrated, cleared in xylene,
and cover-slipped.
The presence of Fos immunoreactivity (Fos-IR) was detected by
optic microscopy as a brown-black reaction product in cell nuclei.
Fos positive cells were counted with the software Image J at the
thoraco-lumbar (T2-L2) and cervical (C1-C5) levels of the spinal
cord on 5 consecutive sections, in the dorsal horn of the gray
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cells per dorsal horn.
2.5. Role of sensory ﬁbres, TRPV1, TRPA1 and NK1 in abdominal
nociception evoked by capsaicin or AITC in rats
To assess the possible contribution of the TRPV1, TRPA1 and NK1
in the nociceptive responses induced by capsaicin (0.1 mg/kg) and
AITC (3 mg/kg), the animals were treated with SB-366791 (a selective
TRPV1 antagonist, 0.25 mg/kg, i.p. or s.c.), camphor (a non-selective
TRPA1 antagonist, 0.25 mg/kg, s.c.), HC-030031 (a selective TRPA1
antagonist, 30 mg/kg, i.p.), aprepitant (a tachykinin NK1 receptor
antagonist, 2.5 mg/kg, i.p.) or the respective vehicles 30 min before
the algogen injection. Then, abdominal nociception was observed
individually for 10 min after the i.p. administration of capsaicin
(0.1 mg/kg), AITC (3 mg/kg) or the vehicle, as described above. The
dose of the antagonists and their treatment time were based on
previous data described in the literature as well as those determined
in pilot experiments (Kopczynska, 2008; Millan et al., 2010).
In order to investigate the effect of TRPV1-positive sensory
ﬁbres on nociception induced by capsaicin or AITC, we used a
desensitisation protocol employing resiniferatoxin, as described
previously (Steiner et al., 2007). The animals were pre-treated
with a single i.p. injection of resiniferatoxin (200 mg/kg) or the
vehicle (10% ethanol and 10% Tween 80 in PBS, 1 mL/kg) under
anaesthesia induced by a mixture of ketamine and xylazine
(90 mg/kg and 3 mg/kg, respectively, i.p.). The animals were tested
7 days after treatment with resiniferatoxin or the vehicle.
To assess whether a complete desensitisation of the TRPV1-
positive ﬁbres had occurred after treatment with RTX, the animals
were submitted to an eye-wiping test, as previously described (Ikeda
et al., 2001; Jakab et al., 2005). For this experiment, 20 mL of 10 mg/mL
capsaicin solution was administered into the eye, and the number of
wiping movements that occurred in a 1-min time interval was
counted. The animals that wiped their eyes no more than 5 times
were considered to be desensitised by the RTX treatment. Subse-
quently, the animals received an i.p. injection of capsaicin (0.1 mg/
kg), AITC (3 mg/kg) or the vehicle, and their nociceptive responses
were observed individually for 10 min, as described above.
2.6. Assessment of the participation of resident peritoneal mast cells
and macrophages in capsaicin- and AITC-elicited abdominal
nociception in rats
The role of resident peritoneal mast cells on capsaicin- and
AITC-induced abdominal nociception in rats was investigated by
using the mast cell membrane stabiliser cromoglycate and the
histaminergic H1 receptor antagonist promethazine. Cromoglycate
(80 mg/kg, i.p.), promethazine (20 mg/kg, i.p.) were administered
1 or 0.5 h, respectively, before the i.p. injection of capsaicin
(0.1 mg/kg), AITC (3 mg/kg), the mast cell degranulator compound
48/80 (0.75 mg/kg, used as a positive control) or the vehicle
(10 mL/kg, i.p.). The nociceptive response was observed individu-
ally for 10 min, as described above. The dose of the drugs and their
treatment time were based on previous data described in the
literature as well as those determined in pilot experiments of our
group using positive controls (Ohta et al., 2003).
To observe the effect of resident peritoneal macrophages in the
nociceptive effect of capsaicin and AITC, we have used the protocol
of peritoneal macrophage depletion as the method described
before (Ribeiro et al., 2000; Kamei et al., 2010). In order to deplete
the macrophage content in the peritoneal cavity, rats were i.p.
injected with PBS (10 mL) under isoﬂurane anesthesia and the
peritoneal cavity was washed three times. Immediately after the
procedure, animals were injected with capsaicin (0.1 mg/kg, i.p.),
AITC (3 mg/kg, i.p.), or vehicle (10 mL/kg, i.p.) and their nociceptiveresponses were observed individually for 10 min, as described
above. Control animals were not submitted to peritoneal macro-
phage depletion, but were anesthetized as described above. We
detected that peritoneal lavage decreased (about 90%) the number
of resident macrophages (data not shown), in accordance with
previous studies (Ribeiro et al., 2000).
2.7. Determination of the histamine and substance P contents in the
peritoneal cavity
To observe if the i.p. injections of either capsaicin or AITC were
capable of inducing the degranulation of mast cells, the histamine
content in the peritoneal ﬂuid was determined, as previously
described (Oliveira et al., 2011). The animals received an i.p. admin-
istration of capsaicin (0.1 mg/kg, i.p.), AITC (3 mg/kg, i.p.) or the
vehicle (10 mL/kg, i.p., 0.95% ethanol and 0.05% Tween 80 in PBS).
After 10 min, the animals were euthanised using a carbon dioxide
chamber, and their peritoneal cavities were washed with 3 mL of PBS
containing 1 mM metronidazole (a histamine methyl transferase
inhibitor used to reduce histamine degradation). Aliquots of the
peritoneal ﬂuids were centrifuged at 12,000 g and 4 1C for 10 min,
and the resulting supernatants were used to evaluate the histamine
content. Next, 150 μL of NaOH (1 M) was added to 400 μL of the
supernatant and incubated with 40 μL of 1% o-phthaldialdehyde for
4 min. Next, 75 μL of HCl (3 M) was added to stop the reaction and
allow for the development of ﬂuorescence. The histamine contents
were determined spectroﬂuorometrically with an excitation wave-
length of 360 nm and an emission wavelength of 450 nm using a
ﬂuorescence photometer. The histamine release was expressed as the
content of histamine (in μg) per mL of peritoneal ﬂuid, as compared
to a standard curve of histamine.
The substance P levels were also measured from an aliquot of
the peritoneal ﬂuid supernatant obtained 10 min after the i.p.
injection of capsaicin, AITC, or the vehicle using a commercially
available enzyme-linked immunosorbent assay (ELISA) according
to the manufacturer′s instructions (Cayman Chemicals Company,
Ann Arbor, USA). For this experiment, the animals received an i.p.
administration of capsaicin (0.1 mg/kg, i.p.), AITC (3 mg/kg, i.p.) or
the vehicle (10 mL/kg, i.p., 0.95% ethanol and 0.05% Tween 80 in
PBS). After 10 min, the animals were euthanised using a carbon
dioxide chamber, and their peritoneal cavities were washed with
3 mL of PBS. Aliquots of the peritoneal ﬂuids were centrifuged at
12,000 g and 4 1C for 10 min, and the resulting supernatants
were used to evaluate the content of substance P, which was
expressed as the SP (in pg) content per mL of peritoneal ﬂuid, as
compared to a standard curve of substance P.
2.8. Mast cell degranulation in vitro
Mast cells from the peritoneal cavities of the rats were puriﬁed on
a Percoll gradient, as described previously (Desouza et al., 2009).
Brieﬂy, the rats were exsanguinated under halothane anaesthesia,
and 10 mL of Krebs-Ringer phosphate solution (pH 7.4) was injected
into their intraperitoneal cavities. The Krebs-Ringer solution had the
following composition (mM): NaCl (150), KCl (6.1), Na2HPO4 (10),
MgSO4 (1.5), CaCl2 (42.9), and glucose (5.6). The abdomen was
carefully massaged, and the peritoneal ﬂuid was withdrawn, placed
in polypropylene centrifuge tubes and centrifuged at 300 g for
5 min at 4 1C. The resulting cell pellet (of which mast cells comprise
10%) was gently resuspended in a small volume of Krebs-Ringer
phosphate solution, layered over the isotonic Percoll gradient and left
at room temperature for 10 min prior to centrifugation (150 g for
25 min at 4 1C). The gradient zone containing the mast cells was
removed and washed twice in Krebs-Ringer phosphate solution.
The purity of the cells in the ﬁnal preparation was 90–95%, and
their viability (as assessed by 0.1% Trypan blue dye exclusion) was
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containing 4105 cells/mL) were warmed to 37 1C for 10 min.
Capsaicin (0.001–10 mM), AITC (1–1000 mM), the vehicle (0.01%
ethanol in Krebs-Ringer phosphate solution), or compound 48/80
(1 μg/mL, used as a positive control) was added to the suspension
(ﬁnal volume of 1 mL). After 15 min of incubation, the reaction was
quenched by placing the test tubes in ice-cold water. The cells were
then centrifuged (300 g for 10 min at 4 1C), and the supernatant
was removed for histamine determination. Then, Krebs-Ringer
phosphate solution (1 mL) was added to the pellet, which was boiled
at 100 1C for 10 min to release the residual histamine. Then, 150 μL of
NaOH (1 M) was added to 400 μL of the supernatant or the re-
suspended pellet and incubated with 40 μL of 1% o-phthaldialdehyde
for 4 min. Next, 75 μL of HCl (3 M) was added to stop the reaction
and allow for the development of ﬂuorescence. The histamine
contents were determined spectroﬂuorometrically with an excitation
wavelength of 360 nm and an emission wavelength of 450 nm using
a ﬂuorescence photometer, as previously described (Oliveira et al.,
2011). The histamine release was expressed as a percentage of the
total cellular content of the amine.2.9. Gastrointestinal transit
We have also observed if capsaicin (0.1 mg/kg) or AITC (3 mg/
kg) i.p. administration alters the normal gastrointestinal transit it
was analysed, as described previously (Holtman et al., 2010).
Rats were housed in cages without food for 18 h. Then, animals
were treated with capsaicin (0.1 mg/kg), AITC (3 mg/kg), or vehicleFig. 1. Intraperitoneal injection of the TRPV1 agonist capsaicin induced a short-term abdo
elicited by the i.p. injection of capsaicin in rats. The animals received an i.p. injection of capsa
kg), and then the nociception time (A) and nociception score (B) were observed for 30 min.
Different doses of capsaicin (0.03–0.3mg/kg) or the vehicle (0.95% ethanol and 0.05% Twee
nociceptive score (D) were observed for 10 min. Each column represents the mean7S.E.M
asterisks denote the signiﬁcance levels: nPo0.05, nnPo0.01, and nnnPo0.001 in compariso
Mann–Whitney test (B); one-way ANOVA followed by Bonferroni′s post-hoc test (C) or the(10 mL/kg, 0.95% ethanol and 0.05% Tween 80 in PBS). Consecu-
tively, rats were given a standard charcoal meal (5% charcoal and
20% Arabic gum, 2 mL) by gavage. Ten minutes after administra-
tion of the charcoal meal, the animals were euthanized and their
stomachs and small intestines were removed. The length of the
intestine (from the pyloric sphincter to the ileo-caecal junctions)
and the distance travelled by the charcoal meal were measured.
The propulsive activity of the gut was evaluated by determining
the percentage of gastrointestinal travelled charcoal, using the
following equation: travelled (%)¼100 (distance travelled/total
gut length).2.10. Myeloperoxidase activity assessment
Myeloperoxidase (MPO) activity was determined as described
before (Sauzem et al., 2009). Animals were i.p. injected with
capsaicin (0.1 mg/kg), AITC (3 mg/kg), or vehicle (10 mL/kg, 0.95%
ethanol and 0.05% Tween 80 in PBS). Ten minutes after, samples of
intestine were used to analyze the MPO activity. Samples were
homogenized in 0.3 mL of sodium acetate buffer (80 mM, pH 5.5)
plus 0.5% hexadecyltrimethylammonium bromide (HTAB), and
centrifuged (10,000 g) at 4 1C for 20 min; supernatants were
used for the assay. Then, 10 μL of supernatant was added to 200 mL
of sodium acetate buffer (80 mM, pH 5.5) and 10 mL of 5-(N,N-
diethylamino)-pentyl-3,4,5-trimethoxybenzoate. After an incuba-
tion period of 3 min at 37 1C, the reaction was stopped on ice
by the addition of 30 mL acetic acid. The visible absorbance
was analyzed on a spectrophotometer at 610 nm, a Fisher Biotechminal nociceptive response. ((A) and (B)) Time-course of the abdominal nociception
icin (CPS, 0.1 mg/kg) or the vehicle (Veh, 0.95% ethanol and 0.05% Tween in PBS,10 mL/
((C) and (D)) Dose–response curve of capsaicin-induced abdominal nociception in rats.
n in PBS, 10 mL/kg) were administered by i.p. injection. The nociceptive time (C) and
. ((A) and (C)) or the median7interquartile range ((B) and (C)) of ﬁve to six rats. The
n to the vehicle-treated group. Student′s “t” test (B); Student′s “t” test followed by the
Kruskal Wallis test followed by Dunn′s test (D).
G. Trevisan et al. / European Journal of Pharmacology 714 (2013) 332–344336Microkinetics BT 2000 (Fisher Scientiﬁc, Pittsburgh, PA, USA) micro-
plate reader. Values were expressed as optical density corrected by
mg of tissue.
2.11. Measurement of plasma protein extravasation
The vascular permeability induced by the i.p. injection of capsai-
cin or AITC was determined according to previously described withFig. 2. Intraperitoneal injection of the TRPA1 agonist allyl isothiocyanate caused short-te
provoked by i.p. injection of AITC in rats. The animals received an i.p. injection of AITC (3 mg/
nociception time (A) and nociception score (B) were observed for 30 min. ((C) and (D)) Dose
(1–10 mg/kg) or the vehicle (0.95% ethanol and 0.05% Tween in PBS, 10 mL/kg) were admi
observed for 10 min. The co-injection of sub-effective doses of capsaicin plus AITC induced n
TRPA1 antagonists. The selective TRPV1 antagonist SB-366791 (0.25 mg/kg, s.c.) plus the
30 min before the i.p. injection of capsaicin (CPS) plus AITC (1 mg/kg, i.p.) diminished the noc
(E)) or the median7interquartile range ((B), (C), and (F)) of ﬁve to six rats. The asterisks den
vehicle-treated group, and ##Po0.01 in comparison to the capsaicin plus AITC-treated gro
Mann–Whitney test (B); one-way ANOVA followed by Bonferroni′s post-hoc test ((C) andsome modiﬁcations (An et al., 2011). The plasma protein extravasa-
tion was observed after 10 min of the injection of capsaicin (0.1 mg/
kg), AITC (3 mg/kg), or vehicle (10 mL/kg, 0.95% ethanol and 0.05%
Tween 80 in PBS). Animals were anesthetized with sodium pento-
barbital (100 mg/kg, i.p.) and the Evans blue (50 mg/mL in saline
solution, NaCl 0.9%) was injected through the tail vein (1 mL/kg, i.v.).
Then, ear or meningeal samples were removed and immersed in N,
N-dimethylformamide at 55 1C for 24 h. Afterwards, the extract ofrm abdominal nociception. ((A) and (B)) Time-course of the abdominal nociception
kg) or the vehicle (Veh, 0.95% ethanol and 0.05% Tween in PBS,10 mL/kg), and then the
–response curve of AITC-elicited abdominal nociception in rats. Different doses of AITC
nistered by i.p. injection and the nociception time (C) and nociception score (D) were
ociception, and these responses were reduced by the co-administration of TRPV1 and
non-selective TRPA1 antagonist camphor (0.25 mg/kg, s.c.) administered systemically
iceptive time (E) and score (F). Each column represents themean7S.E.M. ((A), (C), and
ote the signiﬁcance levels: nPo0.05, nnPo0.01, and nnnPo0.001 in comparison to the
ups (pre-treated with vehicle); Student “t” test (A); Student “t” test followed by the
(E)) or the Kruskal Wallis test followed by Dunn′s test ((D) and (F)).
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Evans blue content in supernatants was quantiﬁed by reading the
optical density at 620 nm (measured in a Plate reader, Bioteck, USA).
The content of Evans blue was compared with a standard curve, and
plasma extravasation was expressed as mmol of Evans blue extracted
per mg of tissue.
2.12. Statistical analysis
The results were expressed as the mean7S.E.M for the nocicep-
tion time and mediator concentration and the median followed by
the interquartile range for the nociception scores. The ED50 values
were reported as the geometric means accompanied by their
respective 95% conﬁdence limits. Parametric data were analysed by
one-way analysis of variance (ANOVA) followed by Bonferroni′s post-
hoc test or by the Student′s “t test when appropriate. Non-parametric
data were analysed either by the Student′s “t” test followed by the
Mann–Whitney test or the Kruskal–Wallis test followed by Dunn′s
test. The ED50 values were determined by non-linear regression
analyses with a sigmoid dose-–response equation using GraphPad
Software 5.0 (GraphPad Software, San Diego, CA, USA). The Emax
(maximum effect for the TRPV1 and TRPA1 agonists) was described
in seconds for the nociception time response or in a percentage
for the maximal nociceptive score (3). The percentages of inhibition
are reported as the mean7S.E.M. obtained in each individualFig. 3. Capsaicin or AITC i.p. injection induced c-fos expression in thoraco-lumbar leve
thoraco-lumbar spinal cord and (B) pooled data representative of the action of i.p. injec
immunoreactivity (LI) in rats 10 min after administration (5 animals for each treat
photomicrograph of each group is an example one section (T2-L2) of the dorsal horn. Eac
per condition in T2-L2 segments; nnnPo0.001 in comparison to the vehicle (Veh)-treateexperiment in relation to the control values. P values less than 0.05
(Po0.05) were considered signiﬁcant.
3. Results
3.1. Characterisation of abdominal nociception induced by i.p.
injections of capsaicin and AITC
The i.p. injection of the TRPV1 agonist capsaicin (0.1 mg/kg)
induced a short-term nociceptive response, observed by the nocicep-
tion time and score, that peaked during the ﬁrst 10 min and
disappeared within 20–30 min after administration (Fig. 1A and B).
The capsaicin-induced nociceptive response was dose-dependent
with calculated values of ED50 and Emax of 0.083 (0.067–0.102) mg/
kg and 563720 s and 0.124 (0.094–0.163) mg/kg and 100% for the
nociception time and score, respectively (Fig. 1C and D).
Similar to the results obtained using capsaicin, i.p. injection of
the TRPA1 agonist AITC (3 mg/kg) was also capable of inducing
short-term nociception, peaking at 10 and lasting for a maximum
of 20 min (Fig. 2A and B). The calculated ED50 and Emax values were
2.3 (1.4–3.9) mg/kg and 514754 s or 3.1 (2.1–4.7) mg/kg and 100%
for nociception time and score, respectively (Fig. 2C and D).
Moreover, we have observed that the co-injection of sub-effective
doses of capsaicin (0.03 mg/kg, i.p.) plus AITC (1 mg/kg, i.p.) induced
nociception (indicated as nociceptive time and nociceptive score).l spinal cord lumbar sections. (A) Photomicrographs of transverse sections of the
tion of capsaicin (CPS, 0.1 mg/kg) or AITC (3 mg/mg) on the expression of c-fos-like
ment). The arrows indicate the c-fos immunoreactive cells. The representative
h column represents the mean7S.E.M. of of Fos-IR-cells per dorsal horn; n≥5 slices
d group one-way ANOVA followed by Bonferroni′s post-hoc test.
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nation of the TRPV1 (SB-366791, 0.25 mg/kg, s.c.) plus the TRPA1
(camphor, 0.25 mg/kg, s.c.) antagonists (9778 or 100% inhibition, for
nociceptive time and score, respectively) (Fig. 2E and F).
Conﬁrming the behavioral ﬁndings and indicating neuronal
activation, capsaicin or AITC i.p. injection caused an increase in the
c-Fos immunoreactivity (Fos-IR) of the dorsal horn cells in the
thoraco-lumbar level of the spinal cord, when compared with
vehicle i.p. injection (Fig. 3A and B). On the other hand, capsaicin,
AITC, or vehicle i.p. treatment did not induce Fos-IR of cells in the
cervical level of the spinal cord (Suppl. Fig. 1A and B).Fig. 4. The effect of TRPA1 and TRPV1 antagonists on agonist-induced nociception. The
nociceptive time (A) and score (B) elicited by capsaicin (CPS) i.p. injection. SB-366791 (0.
injected 30 min before the i.p. administration of capsaicin (0.1 mg/kg), AITC (3 mg/kg) o
(camphor) or the selective (HC-030031) TRPA1 antagonists were able to reduce the
administration. Camphor (0.25 mg/kg, s.c.), HC-030031 (30 mg/kg, i.p.), or the vehicle (1
of capsaicin (0.1 mg/kg), AITC (3 mg/kg) or the vehicle (0.95% ethanol and 0.05% Tween in
score ((B), (D), and (F)) were observed for 10 min. Each column represents the mean7S
rats. The asterisks denote the signiﬁcance levels: nPo0.05 and nnnPo0.001 in compa
###Po0.001 in comparison to the capsaicin- or AITC-treated groups (pre-treated with ve
the Kruskal Wallis test followed by Dunn′s test ((B), (D), and (F)).To avoid supra-maximal stimulation and unnecessary animal
discomfort, we selected the doses of 0.1 mg/kg for capsaicin and
3 mg/kg for AITC with an observational time of 10 min for the next
experiments.
3.2. Role of TRPV1, TRPA1 and positive sensory ﬁbres in abdominal
nociception elicited by capsaicin and AITC
The nociception induced by capsaicin (0.1 mg/kg) was almost
abolished by i.p. pre-treatment with the selective TRPV1 receptor
antagonist SB-366791 (0.25 mg/kg i.p.; 9474 and 100% inhibition,selective TRPV1 antagonist SB-366791 administered systemically diminished the
25 mg/kg, i.p.) or the vehicle (Veh, 1% Tween 80 and 1% DMSO in PBS, 1 mL/kg) was
r the vehicle (0.95% ethanol and 0.05% Tween in PBS, 10 mL/kg). The non-selective
nociceptive time ((C) and (E)) and score ((D) and (F)) provoked by AITC i.p.
% Tween 80, 1% DMSO in PBS, 1 mL/kg) was injected 30 min before the i.p. injection
PBS, 10 mL/kg). Afterwards, the nociception time ((A), (C), and (E)) and nociception
.E.M. ((A), (C), and (E)) or the median7 interquartile range ((B), (D), and (F)) of ﬁve
rison to the vehicle-treated group (pre-treated with vehicle), and #Po0.05 and
hicle); one-way ANOVA followed by Bonferroni′s post-hoc test ((A), (C), and (E)) or
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However, the response induced by AITC (3 mg/kg) was not
prevented by pre-treatment with SB-366791 (Fig. 4A and B). The
antagonism effect of SB-366791 was not related to a neutralizing
effect because we have also injected SB-366791 by subcutaneous
route (0.25 mg/kg, s.c.) and it was also able to reduce capsaicin in a
similar way that was observed to the i.p. injection of this TRPV1
antagonist (9873 and 100% inhibition, for the nociception time
and score, respectively) (data not shown).
Abdominal nociception caused by AITC (3 mg/kg) was mark-
edly reduced by the non-selective TRPA1 antagonist camphor
(0.25 mg/kg, s.c.), with inhibitions of 9572 and 67% for the
nociception time and score, respectively (Fig. 4C and D). A similar
reduction was observed for the selective TRPA1 antagonist (HC-
030031, 30 mg/kg, i.p.), with inhibitions of 9675 and 100% for theFig. 5. The desensitisation of capsaicin-positive ﬁbres decreased the nociceptive
time (A) and score (B) elicited by capsaicin (CPS) and AITC i.p. injections. The
animals were pre-treated with an i.p. injection of resiniferatoxin (RTX, 200 mg/kg)
or the vehicle (Veh, 10% ethanol and 10% Tween 80 in PBS, 1 mL/kg), and after
7 days were administered an i.p. injection of capsaicin (0.1 mg/kg), AITC (3 mg/kg)
or the vehicle (0.95% ethanol and 0.05% Tween in PBS, 10 mL/kg). Afterwards, the
nociception time (A) and nociception score (B) were observed for 10 min. Each
column represents the mean7S.E.M. (A) or the median7 interquartile range (B) of
four rats. The asterisks denote the signiﬁcance levels: nPo0.05 and nnnPo0.001 in
comparison to the vehicle-treated group (pre-treated with vehicle), and #Po0.05
and ###Po0.001 in comparison to the capsaicin- or AITC-treated groups (pre-
treated with RTX); one-way ANOVA followed by Bonferroni′s post-hoc test (A) or
the Kruskal Wallis test followed by Dunn′s test (B).nociception time and score, respectively (Fig. 4E and F). Moreover,
pre-treatment with camphor (0.25 mg/kg) or HC-030031 (30 mg/
kg, i.p.) did not affect capsaicin-induced abdominal nociception
(Fig. 4C–F).
To conﬁrm the ablation of TRPV1- and TRPA1-positive ﬁbres,
wiping movements induced by the administration of capsaicin
(10 mg/mL, 20 mL) into the eye were counted. The rats pre-treated
with RTX (200 mg/kg, i.p., 7 days prior) showed an almost com-
plete reduction in nociception induced by capsaicin when com-
pared with the vehicle-treated animals (12.070.8 and 3.070.3
wiping movements, for the vehicle- and RTX-treated animals,
respectively; Po0.001, Student′s “t” test).
In addition, the desensitisation of TRPV1-positive sensory ﬁbres
caused by pre-treatment with RTX largely reduced capsaicin-
(0.1 mg/kg) and AITC-elicited (3 mg/kg) abdominal nociception
with inhibitions of 73718 and 76715% for the nociception time,
respectively, and 100% for the nociceptive score for both treat-
ments (Fig. 5A and B).
3.3. Participation of substance P and the tachykinin NK1 receptor in
abdominal nociception induced by TRPV1 and TRPA1 agonists
To determine the participation of substance P and its NK1
receptor in nociceptive behaviours induced by either capsaicin or
AITC, we ﬁrst used the selective tachykinin NK1 receptor antago-
nist aprepitant (MK-869). Pre-treatment with aprepitant (2.5 mg/
kg, i.p.) partially, but signiﬁcantly, reduced the nociception time
and score induced by capsaicin (5675 and 50% inhibition,
respectively) and AITC (5378 and 50% inhibition, respectively;
Fig. 6A and B).
Further, we measured the substance P content in the peritoneal
ﬂuid 10 min after i.p. injection of capsaicin (0.1 mg/kg), AITC
(3 mg/kg) or the vehicle (10 mL/kg, i.p.; 0.95% ethanol and 0.05%
Tween 80 in PBS; Fig. 5C). The concentration of substance P in the
peritoneal ﬂuid of the vehicle-treated animals was below the
detection limit of the high-sensitivity EIA kit (3.9 pg/mL). How-
ever, treatment with capsaicin and AITC signiﬁcantly elevated the
concentration of substance P in the peritoneal ﬂuid (1273 and
1272 pg/mL, respectively; Fig. 6C).
3.4. Role of resident peritoneal mast cells and macrophages in
abdominal nociception induced by TRPV1 and TRPA1 agonists
Afterwards, we evaluated the possible participation of mast
cells in nociception elicited by capsaicin and AITC. Pre-treatment
with the mast cell membrane stabiliser cromoglycate (80 mg/kg,
i.p.) did not affect the nociceptive responses elicited by capsaicin
(0.1 mg/kg) or AITC (3 mg/kg) (Fig. 7A and B). Nevertheless,
abdominal nociception trigged by the mast cell degranulator
compound 48/80 was almost abolished by cromoglycate (inhibi-
tions of 9075 and 100%, for the nociception time and score,
respectively). Similarly, pre-treatment with the H1 receptor
antagonist promethazine did not affect nociception induced by
capsaicin or AITC, but markedly reduced nociception induced by
compound 48/80 (inhibitions of 9176 and 100% for the nocicep-
tion time and score, respectively; Fig. 7C and D).
In addition, neither the i.p. administration of capsaicin (0.1 mg/
kg) nor AITC (3 mg/kg) was capable of altering the histamine
concentration in the peritoneal ﬂuid when compared with the
vehicle-treated animals, while the i.p. injection of compound 48/
80 (0.75 mg/kg) signiﬁcantly increased the histamine content of
the peritoneal ﬂuid (2.6-fold, when compared to vehicle; Fig. 8A).
Accordingly, incubation of the isolated peritoneal mast cells
with capsaicin (0.001–10 mM) and AITC (1–1000 mM) in vitro did
not induce the release of histamine (Fig. 8B and C). In contrast,
Fig. 6. The selective tachykinin NK1 receptor antagonist (MK-869) reduced the nociceptive time (A) and score (B) elicited by capsaicin (CPS) and AITC i.p. injections. The
animals were pre-treated with an i.p. injection of MK-869 (2.5 mg/kg) or the vehicle (PBS, 1 mL/kg), and after 30 min received an i.p. injection of capsaicin (0.1 mg/kg), AITC
(3 mg/kg) or the vehicle (Veh, 0.95% ethanol and 0.05% Tween in PBS, 10 mL/kg). Afterwards, the nociception time (A) and nociception score (B) were observed for 10 min.
(C) The i.p. injection of either capsaicin or AITC induced the release of substance P (SP) in the peritoneal cavity. The SP content was evaluated in the peritoneal ﬂuid 10 min
after the i.p. administration of capsaicin (0.1 mg/kg), AITC (3 mg/kg) or the vehicle (0.95% ethanol and 0.05% Tween in PBS, 10 mL/kg). Each column represents the mean7S.
E.M. ((A) and (C)) or the median7 interquartile range (B) of ﬁve rats (N.D., not detectable). The asterisks denote the signiﬁcance levels: nPo0.05 and nnnPo0.001 in
comparison to the vehicle-treated group (pre-treated with vehicle), and #Po0.05 and ###Po0.001 in comparison to the capsaicin- or AITC-treated groups (pre-treated with
vehicle); one-way ANOVA followed by Bonferroni′s post-hoc test ((A) and (C)) or the Kruskal Wallis test followed by Dunn′s test (B).
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the total histamine content of the mast cells in vitro.
Moreover, we observed that peritoneal macrophage depletion
by repeated peritoneal lavage was not able to decrease the
nociceptive time (452754 and 456723 s, for depleted or control
animals, respectively) and score (2 (2–3) and 2 (2–2.75) score
medians (25–75 percentiles), for depleted or control animals,
respectively) induced by capsaicin administration (0.1 mg/kg, i.
p.). In addition, AITC (3 mg/kg, i.p.) induced nociceptive time
(423763 and 372735 s, for depleted or control animals, respec-
tively) or score (2 (1–3) and 2 (1.25–2.75) score medians (25–75
percentiles) for depleted or control animals, respectively) were
unaltered by the macrophage depletion protocol. Vehicle i.p.
injection in control or depleted animals did not induce nociception
(data not shown).
3.5. Effect of capsaicin or AITC i.p. injection on gastrointestinal
transit, gut inﬂammation or plasma extravasation
Demonstrating that TRPA1 and TRPV1 agonists did not alter
gastrointestinal function or produced gastrointestinal inﬂammation,capsaicin (0.1 mg/kg, i.p.) or AITC (3 mg/kg, i.p.) i.p. injection did not
alter gastrointestinal transit or induced MPO activity when
observed 10 min after administration (Suppl. Fig. 2A and B). TRPA1
and TRPV1 agonists did not produce systemic effects thus the
i.p. injection of capsaicin (0.1 mg/kg, i.p.) or AITC (3 mg/kg, i.p.)
was not able to induce plasma extravasation in peripheral and
central tissues, such as ear and meningeal samples, after 10 min of
i.p. administration (Suppl. Fig. 3A and B).4. Discussion
Irritation of the peritoneum by chemical substances induces
abdominal pain, which is a common complaint in many areas of
medical practice. However, little is known about the role of TRPV1
and TRPA1 in this painful condition. In the present study, we focused
on the mechanisms involved in abdominal pain induced by TRPV1
and TRPA1 agonists in rats. We observed that an injection of either
capsaicin or AITC into the rat peritoneum induces nociception
mediated by TRPV1 and TRPA1 receptor activation. Furthermore,
stimulation of TRPV1-positive sensory ﬁbres triggers the release of
Fig. 7. Capsaicin- and AITC-induced nociceptive responses are independent of mast cell activation. Cromoglycate (a mast cell membrane stabiliser) and the H1 histaminergic
receptor antagonist (promethazine) were not able to reduce the nociceptive time ((A) and (C)) and score ((B) and (D)) elicited by the i.p. injection of either capsaicin (CPS) or
AITC. The animals were pre-treated with an i.p. injection of promethazine (20 mg/kg) or cromoglycate (80 mg/kg) and after 30 or 60 min, respectively, received an i.p.
injection of capsaicin (0.1 mg/kg), AITC (3 mg/kg), compound 48/80 (0.75 mg/kg, positive control) or the vehicle (Veh, 0.95% ethanol and 0.05% Tween in PBS, 10 mL/kg).
Afterwards, the nociception time ((A) and (C)) and nociception score ((B) and (D)) were observed for 10 min. Each column represents the mean7S.E.M. ((A) and (C)) or the
median7 interquartile range ((B) and (D)) of ﬁve rats. The asterisks denote the signiﬁcance levels: nPo0.05 and nnnPo0.001 in comparison to the vehicle-treated group
(pre-treated with vehicle), and #Po0.05 and ###Po0.001 in comparison to the compound-48/80-treated group (pre-treated with the vehicle); one-way ANOVA followed by
Bonferroni′s post-hoc test ((A) and (C)) or the Kruskal Wallis test followed by Dunn′s test ((B) and (D)).
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tor but not by mast cell degranulation.
We ﬁrst observed that intraperitoneal injections of capsaicin or
AITC are able to induce short-term abdominal nociception in a
dose-dependent manner and with similar efﬁcacy. Analysis of the
Emax values showed that both agonists were very effective, reach-
ing the maximal score on the abdominal nociception scale (3) and
presenting nociception over nearly the entire observation period
(600 s). Similarly, it has been demonstrated that abdominal pain
induced by peritoneal irritation in humans is very severe and
short-lived (Mactier et al., 1998). Although capsaicin and AITC
were equiefﬁcacious, the TRPV1 agonist was approximately 25-
fold more potent than the TRPA1 agonist. This result is consistent
with previous studies showing that capsaicin is more potent than
allyl isothiocyanate in inducing depolarisation of somatic and
visceral nociceptors and pain/nociception in the skin and viscera
(Andrade et al., 2006, 2008; Brozmanova et al., 2012; Weller et al.,
2011). Conﬁrming our behavioral ﬁndings, we observed that i.p.
capsaicin and AITC were able to increase the Fos-IR in dorsal horn
cells of the spinal cord at the thoraco-lumbar level, but not at
cervical level. These ﬁndings are in accordance with the literature
that demonstrates that i.p. injection of the irritant substance acetic
acid caused nociception and Fos-IR mainly at the thoraco-lumbar
levels of the spinal cord (where there are the spinal terminations
of afferent ﬁbers that innervates the peritoneum), but not at
cervical level (indicating a selective stimulation of the peritoneal
afferent ﬁbers) (Lantéri-Minet et al., 1993; Sinniger et al., 2005). In
addition, we have observed that capsaicin or AITC i.p. injection didnot alter gut function or induce gut inﬂammation, however, no
systemic inﬂammatory effects were observed. Together, these
results indicated that the nociceptive effect induced by capsaicin
or AITC i.p. injection was caused by a local action of agonists on
peritoneum sensory ﬁbers.
In the present study, capsaicin and AITC were selective in
inducing pain through TRPV1 and TRPA1 stimulation because the
abdominal nociception induced by these agonists was fully abolished
by pre-treatment with either TRPV1 or TRPA1 antagonists, respec-
tively. A recent study reported that some aversive and nociceptive
actions resulting from high concentrations of AITC (41 mM) in mice
are mediated by TRPV1 (Everaerts et al., 2011). In our study,
AITC seems to be selective for TRPA1 because the selective TRPV1
antagonist SB366791 was not capable of altering AITC-induced
nociception in a dose where it fully prevented capsaicin-induced
abdominal nociception. One may also argue that camphor is a TRPV1
agonist at high concentrations (Xu et al., 2005). However, this activity
was not observed in our experimental setting because camphor did
not induce nociception alone or potentiate capsaicin- or AITC-
induced nociception, as expected for a TRPV1 agonist. Moreover,
the selective TRPA1 antagonist, HC-030031, was also able to reduce
the nociception induced by AITC and not capsaicin effects. These
results conﬁrm the data obtained with the poorly selective TRPA1
antagonist camphor.
It was previously demonstrated that TRPV1 activation may cross-
sensitise TRPA1 or vice versa (Akopian, 2011). However, it is unlikely
that cross-sensitisation occurred in the abdominal pain induced by
either the TRPV1 or TRPA1 agonists because selective antagonism of
Fig. 8. Evaluation of the histamine release induced by capsaicin and AITC in vivo (A) and in vitro ((B) and (C)). (A) The histamine levels were evaluated in the peritoneal ﬂuid
10 min after the i.p. administration of capsaicin (CPS, 0.1 mg/kg), AITC (3 mg/kg), compound 48/80 (0.75 mg/kg, positive control), or the vehicle (Veh, 0.95% ethanol and
0.05% Tween in PBS, 10 mL/kg). ((B) and (C)) The histamine released from the isolated rat pleural mast cells was also measured in the presence of capsaicin (0.001–10 mM),
AITC (1–1000 mM), compound 48/80 (1 mg/mL, positive control) or the vehicle (0.01% ethanol in Krebs-Ringer phosphate solution). Each column represents the mean7S.E.M.
of four rats or four samples. The asterisks denote the signiﬁcance levels: nPo0.05 and nnnPo0.001 in comparison to the vehicle-treated group; one-way ANOVA followed by
Bonferroni′s post-hoc test.
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AITC or capsaicin. However, cross-sensitisation may occur with non-
selective irritants. The intraperitoneal injection of acetic acid is one of
the oldest and most studied models of abdominal pain in rodents
(Porreca et al., 1987). Nociception caused by acetic acid is reduced
by both TRPV1 and TRPA1 antagonists and also by ablation of
TRPV1-positive ﬁbres in rodents (Ikeda et al., 2001; Pereira et al.,
2012). Moreover, acetic-acid-induced abdominal pain is mediated by
TRPV1-positive ﬁbres, mast cells, and macrophages in rodents (Ikeda
et al., 2001; Ribeiro et al., 2000). Because TRPV1 and TRPA1 are
expressed in somatic and visceral sensory neurons as well as in mast
cells (Biro et al., 1998; Malin et al., 2011; Prasad et al., 2008; Stander
et al., 2004; Weller et al., 2011), we further investigated the role
of mast cells and sensory ﬁbres in the abdominal pain caused by
capsaicin and AITC.
The peritoneal cavity contains both visceral and somatic sen-
sory innervations (Flasar and Goldberg, 2006; Lantéri-Minet et al.,
1993). It has been well recognised that systemic treatment with
TRPV1 agonists in rodents cause a discerning degeneration of
TRPV1-expressing primary sensory ﬁbres, mainly peptidergic C
ﬁbres (Ferreira et al., 2004; Hsieh et al., 2008; Kopczynska, 2008).
Because TRPA1 and TRPV1 are co-expressed in sensory neurons,treatment with RTX reduces the expression of both TRPV1 and
TRPA1 (Pecze et al., 2009). Accordingly, we observed that systemic
treatment with RTX signiﬁcantly reduced both capsaicin- and
AITC-elicited abdominal nociception. Similar nociception results
were found with the subcutaneous injection of either capsaicin or
AITC into the paw skin of mice and rats (Andrade et al., 2008;
Massaad et al., 2004). Collectively, our data clearly showed the
essential role of primary sensory afferent ﬁbres expressing TRPV1
and TRPA1 in the capsaicin- and AITC-induced abdominal noci-
ceptive responses in rats.
An important feature of TRPV1- and TRPA1-positive ﬁbres is the
presence of neuropeptide substance P (Bautista et al., 2005; Story
et al., 2003). Furthermore, the release of substance P is a critical
mechanism that is associated with nociception provoked by the s.c.
administrations of capsaicin and AITC of experimental animals and
humans (Anand and Bley, 2011; Andrade et al., 2008; Banvolgyi et al.,
2004; Massaad et al., 2004; Santos and Calixto, 1997). Similarly to the
skin, pre-treatment with a selective NK1 antagonist largely reduced
abdominal nociception induced by intraperitoneally injected capsai-
cin and AITC. Our results also indicate that the NK1 receptor is
activated by substance P released from sensory neurons, because we
also observed that the administration of either capsaicin or AITC
G. Trevisan et al. / European Journal of Pharmacology 714 (2013) 332–344 343induced an increase of substance P in the peritoneal ﬂuid at the dose
and time that caused nociception.
In addition to pain, substance P may also cause neurogenic
inﬂammation by inducing plasma extravasation, as well as activat-
ing resident immune cells such as mast cells (Geppetti et al., 2008;
Richardson and Vasko, 2002). Of note, we detected that the
intraperitoneal injection of capsaicin or AITC produced plasma
extravasation in the rat peritoneum (data not shown). Moreover, it
has been described that substance P is capable of inducing mast
cell degranulation, provoking the release of histamine (Ansel et al.,
1993; Ogawa et al., 1999; Okada et al., 1999; Suzuki et al., 1995,
1999). However, neither the mast cell membrane stabiliser cro-
moglicate nor the H1 receptor antagonist promethazine were able
to reduce the abdominal nociceptive responses induced by either
capsaicin or AITC. In addition, we failed in detecting an increase in
the histamine content in the peritoneal ﬂuid of rats after intraper-
itoneal injections of capsaicin and AITC. Accordingly, the concen-
tration of substance P was markedly elevated in the peritoneal
ﬂuid after the capsaicin and AITC injections, but the levels were
several orders of magnitude lower than that necessary to cause
histamine release in rat peritoneal mast cells in vitro (Ogawa et al.,
1999; Suzuki et al., 1995).
Because TRPA1 and TRPV1 are expressed in mast cells (Biro
et al., 1998; Prasad et al., 2008; Stander et al., 2004), we further
conﬁrmed the potential ability of their agonists in directly indu-
cing mast cell degranulation. Moreover, the ability of capsaicin in
inducing mast cell degranulation in vitro is still controversial and
was investigated only in cell lines and in bone-marrow-derived
mast cells (Biro et al., 1998; Giudice et al., 2007). Currently, the
direct activation of TRPV1 and TRPA1 in the mature peritoneal
mast cells of rats has not been documented. In accordance with
our in vivo results, capsaicin and AITC failed to provoke histamine
release by the peritoneal mast cell of rats in vitro in concentrations
that were efﬁcacious in the activation sensory neurons (Caterina
et al., 2000; Jordt et al., 2004). Thus, TRPA1 and TRPV1 agonists do
not seem to induce a direct degranulation of mature peritoneal
mast cells. We next asked whether peritoneal mast cell degranula-
tion is able to cause pain and histamine release. The intraperito-
neal injection of a mast cell degranulator (compound 48/80)
caused abdominal nociception and increased the peritoneal hista-
mine concentration, which was fully prevented by cromoglycate
and promethazine. This ﬁnding demonstrates clearly that perito-
neal mast cell activation is able to cause abdominal nociception
through histamine release, but this mechanism is not implicated in
the nociceptive responses to selective TRPV1 and TRPA1 agonists.
We have also observed that resident peritoneal macrophages were
not involved in the abdominal nociceptive responses induced by
capsaicin or AITC i.p. injection.
The TRPV1 and TRPA1 receptors have been highlighted as
important sensors of noxious stimulus in different pain models,
including visceral and pancreatic pain (Schwartz et al., 2011;
Moran et al., 2011). However, in this study we have proposed to
observe the participation of these channels in abdominal pain,
which is an important feature in clinical settings (Flasar and
Goldberg, 2006; Mactier et al., 1998). Until now, TRPV1 and TRPA1
antagonists are still not used in the clinical practice, but different
evidences have pointed to a possible use of these substances for
pain treatment (Moran et al., 2011). Collectively, our ﬁndings
suggest that TRPV1 and TRPA1 stimulation in the peritoneum
produces abdominal nociception that is mediated by sensory ﬁbres
and substance P but not by mast cells and histamine or macro-
phages. Because irritant substances, such as some peritoneal
dialysis solutions and chemotherapy drugs, may produce pain
when intraperitoneally injected and lead to the activation of
TRPV1 and TRPA1 receptors, our results may beneﬁt the under-
standing and treatment of abdominal pain.Acknowledgments
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